Please Wait...

Barbara Clendenen

Translation skills

Main profile

Barbara Clendenen, MBA
Barbara Clendenen, MBA
Director, Business Development, Drug Safety and Regulatory

Barbara Clendenen, MBA, designs Pharmacovigilance and Regulatory solutions that increase compliance and reduce risk for life science organizations. She has over 20 years of experience blending both science and business expertise to assist pharmaceutical, biotech, medical device, and CRO clients in meeting research and post marketing goals. She began her career as a research scientist in Immunology and Oncology.  Since 1998, she has held pivotal roles in business development and sales management within the scientific and clinical research industry for Becton Dickinson, Fisher Scientific, and Bio-Rad. Prior to joining Bioclinica in 2015, she led the Business Development Team at Quorum Review IRB, developed the organization's entry into the hospital and AMC market, and participated in CIRB (Consortium of Independent Review Boards). Barbara graduated from University of Washington with a Bachelor's degree in Microbiology and from Seattle University with a Master's in Business Administration.

Blogs

The electronic common technical document (eCTD) is an interface for the pharmaceutical industry to transfer regulatory information based on the Common Technical Document (CTD) format, which is an agreed common format for applications that will be acceptable in all three ICH-Regions (US, EU & Japan) and other countries.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

RT @ACROhealth: @MaryWolleyRA Mary Woolley @ResearchAmerica: 80% have heard of #clinicaltrials. 75% think trial participation is as importa…
bioclinica (Yesterday)
#Pharma & CROs: Ck it out! Enterprise tools for site payments automation & reconciliation. https://t.co/LFri5Kv0WC
bioclinica (Yesterday)
Can having a geographically diverse network of high performing sites mean fewer sites are needed in a trial? Can ha… https://t.co/tZYvWrNzHg
bioclinica (Yesterday)
Confidence is a good thing ─ especially in the clinical supply chain for global clinical trials. Here’s how accurat… https://t.co/70VwXCwuWw
bioclinica (2 days ago)
#Pharmacovigilance: Get up-to-speed on latest ind. trends & best practices + hear how others R meeting today's most… https://t.co/3YNpB9hTXs
bioclinica (5 days ago)
Announcing our new Chief of Staff @bioclinica Adrienne Rossi! Also welcoming President Bioclinica Site Network Eliz… https://t.co/toB9yk534k
bioclinica (1 week ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen